Newly Funded Projects Aim to Improve Vaccine Use, Preventive Care in IBD

Newly Funded Projects Aim to Improve Vaccine Use, Preventive Care in IBD
Some $1 million in funding will go to three projects aimed at addressing gaps in vaccine use and communication among healthcare providers and patients with inflammatory bowel disease (IBD). Made possible through Pfizer Global Medical Grants (GMG), the recipients were announced by the American College of Gastroenterology (ACG), the Crohn’s & Colitis Foundation, and the American Gastroenterological Association (AGA). The GMG’s goal is to collaborate with the global healthcare community to improve patient outcomes. “These projects were selected for their potential to overcome barriers by helping to identify and establish best practices around improving vaccine utilization and preventive health maintenance for patients with IBD,” said a news release by Francis A. Farraye, MD, director of the Inflammatory Bowel Disease Center at Boston Medical Center, and chair of the steering committee for the organizations’ partnership. “The selected projects also have the potential to be easily replicated, broadly disseminated, and widely adopted within the IBD community.” The recipients are: Improving Vaccine Utilization and Preventive Health Maintenance in IB
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *